These are the top 15 Parkinson's disease centers in the United States

Identifying the top 15 Parkinson's disease centers in the United States requires examining multiple layers of evaluation: national hospital rankings, Parkinson's Foundation Center of Excellence designations, multidisciplinary team structures, research output, and access to advanced interventions such as deep brain stimulation (DBS). The number of people living with Parkinson's disease in the U.S. is expected to rise to 1.2 million by 2030, and nearly 40 percent of current patients do not receive care from a clinician with advanced neurological disease and disorders training. 1 The centers profiled below represent the highest tier of specialized care available in the country today.

What Qualifies a Center as a Leader in Parkinson's Care

The Parkinson's Foundation Global Care Network sets a rigorous standard for designation. Centers must demonstrate exemplary multidisciplinary care, a vital role in leading the Parkinson's disease field in advancing clinical research, leadership in professional training, and impactful patient education and community outreach. 2 Designated Centers of Excellence are recertified every three years in a process that evaluates each center's clinical accomplishments, team composition, and research activity. Together, these centers deliver care to more than 127,000 patients worldwide. 3

National rankings from Newsweek and Statista add another dimension to the evaluation. Their America's Best Hospitals for Specialized Care 2026 assessment ranks institutions based on clinical performance, patient outcomes, and expert input from health care professionals working in neurology. 4 Institutions that appear consistently across both the Parkinson's Foundation network and independent hospital ranking systems represent the strongest convergence of clinical and research excellence.

The Top 15 Parkinson's Disease Centers in the United States

Multidisciplinary Team Structure and What Patients Should Expect

A defining feature of top-tier Parkinson's centers is the multidisciplinary team model. At institutions such as Mayo Clinic, the care team integrates neurologists, neurosurgeons, and rehabilitation experts to deliver personalized treatment plans. 5 Washington University in St. Louis brings together neurologists, radiologists, neuropsychologists, physical therapists, occupational therapists, chemists, and data scientists under one roof. 6 This breadth of expertise is not incidental; it reflects the complexity of Parkinson's disease, which affects movement, cognition, mood, speech, and swallowing.

Patients seeking care at a designated center should anticipate comprehensive intake assessments covering mobility, balance, posture, strength, flexibility, coordination, speech, and swallowing, followed by individualized care plans that evolve as symptoms progress. 7 Support group programming, caregiver education, and community outreach are also standard features. The University of Pennsylvania's center, for example, offers structured support groups for specific populations, including newly diagnosed patients, those who have undergone deep brain stimulation, and individuals with early-onset Parkinson's. 8

Advanced Treatments Available at Leading Centers

Deep brain stimulation (DBS) is one of the most significant surgical interventions available for Parkinson's disease, and access to high-volume DBS programs is a key differentiator among top centers. The U.S. DBS market for Parkinson's disease was valued at $685.4 million in 2026 and is projected to expand to $1,513.38 million by 2035, advancing at a 9.20% compound annual growth rate. 9 Academic medical centers with dedicated movement disorder programs are expanding DBS surgical volumes as regulatory pathways for next-generation neuromodulation systems are streamlined. 9

Beyond DBS, leading centers offer MR-guided focused ultrasound, access to active clinical trials, and emerging stem cell research. A clinical trial published in Nature Medicine in July 2026 reported the first human results for a stem cell-derived dopamine therapy, involving eight participants with moderate Parkinson's across two dose groups. 10 Centers such as UCSF, Johns Hopkins, and Northwestern are consistently among the sites enrolling patients in high-impact trials. Typical procedural cost benchmarks for reference include DBS surgery ranging from $70,000 to $110,000 and MR-guided focused ultrasound from $45,000 to $85,000 in U.S. hospital settings. 11

Geographic Access and Coverage Gaps

Despite the depth of the national network, geographic access remains a structural challenge. The Parkinson's Foundation expanded its Global Care Network in July 2026 with five new designations, including the first-ever Centers of Excellence in Missouri, New Jersey, and Washington state, reflecting an intentional effort to extend coverage beyond established medical hubs. 12 Froedtert Hospital in Milwaukee and Ohio State University Wexner Medical Center in Columbus were both promoted to Centers of Excellence in December 2025, further broadening the Midwest's access to top-tier care. 13

Patients in rural or underserved areas who cannot readily access a designated center may benefit from telehealth consultations with movement disorder specialists or referrals through regional comprehensive care centers. The NINDS Centers of Excellence program, developed in honor of former Congressman Morris K. Udall, supports both preclinical and clinical research on Parkinson's disease nationally and helps fund the infrastructure that makes specialized outreach possible. 14 Patients seeking an appointment at a Center of Excellence can contact the Parkinson's Foundation Helpline for guidance on the nearest designated facility.

Research Output and the Role of Biomarkers

The Parkinson's Progression Markers Initiative (PPMI) has generated some of the most important long-term longitudinal data on Parkinson's disease available. A study published in the Annals of Neurology in May 2026 reported findings from 344 participants with sporadic Parkinson's disease followed for up to 11 years, highlighting significant heterogeneity within early PD populations and affirming the importance of biologically-based clinical criteria. 15 Authors from Northwestern University, the University of Iowa, UCSF, the University of Pittsburgh, Stanford University, and the University of Pennsylvania contributed to this research, illustrating how the top centers function as a collaborative research ecosystem rather than competing siloes.

Biomarker development is among the highest priorities at centers including Washington University in St. Louis, where researchers are working to identify objective measures that can track disease progression, predict treatment response, and enable earlier diagnosis. 6 Just as cholesterol metrics guide cardiovascular care, validated PD biomarkers have the potential to transform how clinicians monitor disease course and evaluate intervention efficacy across all patient populations.

Key Eligibility and Access Considerations

Patients and families should understand that access to top Parkinson's centers involves several practical variables beyond geography. Insurance coverage for DBS surgery, specialist consultations, and clinical trial participation varies significantly by plan and provider network. Initial neurologist consultations in U.S. hospital systems typically range from $300 to $400, while complex diagnostic workups can reach $1,800 to $2,500. 11 Many of the leading centers have dedicated financial counseling teams to help patients navigate coverage determinations before committing to a treatment pathway.

Referral requirements, wait times for movement disorder specialists, and the availability of on-site rehabilitation services also vary. Patients who receive care outside of a designated center are not without options; regional comprehensive care centers and community-based Parkinson's organizations, such as the American Parkinson Disease Association's network of nine Centers for Advanced Research, provide meaningful access to evidence-based support and clinical coordination. 6 The critical factor for any patient is ensuring that the treating team includes clinicians with subspecialty training in movement disorders, since general neurology training alone may not be sufficient for the nuanced management that Parkinson's disease requires across its progressive stages.

Sources

1. Parkinson's Foundation - Centers of Excellence Designation Criteria and Network Overview (parkinson.org)
2. Parkinson's Foundation - Global Care Network Standards and Center Requirements (parkinson.org)
3. Our Parkinson's Place - Center of Excellence Network Overview (ourparkinsonsplace.blogspot.com)
4. Newsweek - America's Best Hospitals for Specialized Care 2026: Neurological Care (rankings.newsweek.com)
5. CuresBoost - Top 10 Best Neuroscience Hospitals in USA 2025 Guide (curesboost.com)
6. American Parkinson Disease Association - Parkinson's Research at Washington University APDA Center for Advanced Research (apdaparkinson.org)
7. Oasis Rehabilitation and Nursing - How a Parkinson's Movement and Disorder Center Can Keep Loved Ones Independent Longer (oasisrehabandnursing.com)
8. University of Pennsylvania Perelman School of Medicine - Parkinson's Disease and Movement Disorders Center (med.upenn.edu)
9. MarkWide Research - US Deep Brain Stimulation in Parkinson's Disease Market Size and Industry Trends Forecast 2026-2036 (markwideresearch.com)
10. The Movement Disorder Journal - Inside a Big Week for Parkinson's Research: Stem Cells, a New Culprit Protein, and a Possible Shield for Dying Neurons (themovementdisorderjournal.com)
11. Bookimed - Parkinson's Disease Treatment in United States of America: Costs 2026 (us-uk.bookimed.com)
12. PR Newswire - Parkinson's Foundation Expands Global Care Network with Five New Designations (prnewswire.com)
13. PR Newswire - Parkinson's Foundation Names Centers of Excellence in Ohio and Wisconsin (prnewswire.com)
14. National Institute of Neurological Disorders and Stroke - Parkinson's Disease Research Centers of Excellence (ninds.nih.gov)
15. Annals of Neurology via Exa.ai - Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative (doi.org)